收稿日期: 2024-09-12
修回日期: 2024-12-11
网络出版日期: 2025-04-07
基金资助
上海市自然科学基金(23ZR1469500);上海市加强公共卫生体系建设三年行动计划(2023-2025年)重点学科项目(GWVI-11.1-12)
Changes of Tsc22d3 expression in NK cell in liver of mice infected with Schistosoma japonicum and the effect on the cytotoxicity of NK cells
Received date: 2024-09-12
Revised date: 2024-12-11
Online published: 2025-04-07
Supported by
Shanghai Natural Science Foundation(23ZR1469500);Shanghai Three-Year Initiative Plan for Strengthening Public Health System Construction in Shanghai (2023-2025) Key Discipline Project(GWVI-11.1-12)
目的 探讨Tsc22结构域家族成员3(Tsc22 domain family member 3,Tsc22d3)在日本血吸虫感染小鼠肝脏自然杀伤(natural killer,NK)细胞亚群中的表达及其对NK细胞杀伤功能的影响。方法 将42只C57BL/6 雌性小鼠经腹部贴片法感染日本血吸虫尾蚴(20 ± 1 条/只),分别在感染前、感染后第4、6周取6只小鼠剖杀,磁珠分选富集肝脏NK细胞,并进行单细胞测序,分析Tsc22d3在NK细胞的表达及活化的信号通路。其余24只小鼠随机均分为感染组和对照组,每组12只,感染后第4、6周各取6只小鼠进行麻醉,分离小鼠肝非实质细胞,流式细胞术检测Tsc22d3在对照组和感染组小鼠肝脏NK细胞中的表达变化。采用脂质体转染法将空载质粒、Tsc22d3表达质粒转染NK92细胞,获得空载质粒对照组(NC组)和Tsc22d3过表达NK92细胞组(Tsc22d3+NK92细胞组);用可溶性虫卵抗原(SEA)刺激Tsc22d3+NK92组和NC组24 、48 h,流式细胞术和实时荧光定量PCR(qPCR)检测NK细胞中γ干扰素(IFN-γ)和穿孔素(Prf1)表达的变化。使用GraphPad Prism9软件进行统计学分析,两组比较采用t检验。结果 单细胞测序结果提示,与感染前小鼠(2.41)相比,感染后第4周(3.16)、第6周(3.76)Tsc22d3的表达持续增加,Tsc22d3高表达于NK的C3亚群,KEGG结果显示C3亚群中NK细胞介导的细胞毒性通路显著活化;流式细胞术结果显示,感染组第4、第6周小鼠肝脏NK细胞中Tsc22d3+NK的占比分别为(0.24 ± 0.01)%、(1.40 ± 0.14)%,高于对照组的(0.12 ± 0.02)%(t = 12.110、22.010,均P < 0.01)。SEA刺激24 h后Tsc22d3+NK92组中IFN-γ、Prf1的阳性细胞的占比分别为(1.66 ± 0.15)%、(53.23 ± 0.81)%,高于NC组的(0.88 ± 0.13)%、(29.93 ± 1.85)%(t = 6.800、20.010,均P < 0.01)。SEA刺激24 h后,Tsc22d3+NK92组中IFN-γ、Prf1的mRNA相对转录水平分别为1.53 ± 0.24、1.41 ± 0.04,均高于NC组的1.00 ± 0.07、1.00 ± 0.14(t = 3.573、4.973,均P < 0.05、0.01);SEA刺激48 h后Tsc22d3+NK92组中IFN-γ、Prf1的mRNA相对转录水平分别为2.06 ± 0.39、1.54 ± 0.26,均高于NC组的1.06 ± 0.44、1.00 ± 0.04(t = 2.953、3.588,均P < 0.05)。结论 日本血吸虫感染进程中Tsc22d3高表达于肝脏NK的C3亚群,Tsc22d3高表达可增强NK细胞的杀伤功能。
关键词: 日本血吸虫; Tsc22结构域家族成员3; 肝纤维化; 自然杀伤细胞
徐方方 , 陈权 , 胡媛 , 曹建平 . Tsc22d3在日本血吸虫感染小鼠肝脏NK细胞中的表达及对NK杀伤功能的影响[J]. 中国寄生虫学与寄生虫病杂志, 2025 , 43(2) : 175 -180 . DOI: 10.12140/j.issn.1000-7423.2025.02.004
Objective To investigate the expression of Tsc22 domain family member 3 (Tsc22d3) expression in natural killer (NK) cell subsets in liver of mice infected with Schistosoma japonicum and its effect on the cytotoxicity of NK cells. Methods Forty-two female C57BL/6 mice were infected with S. japonicum cercariae (20 ± 1 per mouse) by abdominal patch method. Six mice were sacrificed before infection and at the 4th and 6th weeks after infection respectively. NK cells in the liver were enriched by magnetic bead sorting and single-cell sequencing was performed to analyze the expression of Tsc22d3 in NK cells and the activated signaling pathways. The remaining 24 mice were randomly divided into an infection group and a control group, with 12 mice in each group. At the 4th and 6th weeks after infection, 6 mice in each group were anesthetized and non-parenchymal cells in the liver were isolated. The Tsc22d3 expression was detected in mouse hepatic NK cells in the control and infection groups using flow cytometry. Empty plasmid and Tsc22d3 plasmid were transfected into NK92 cells to obtain the empty plasmid control group (NC group) and the Tsc22d3 overexpression NK92 cell group (Tsc22d3+NK92 group) by using liposome transfection method. NK92 cells in the Tsc22d3+NK92 group and the NC group were stimulated with soluble egg antigen (SEA) for 24 or 48 h, and the expression of interferon-γ (IFN-γ) and perforin 1 (Prf1) was detected in NK cells using flow cytometry and real-time quantitative fluorescence PCR (qPCR) assay. All statistical analyses were performed with the software GraphPad Prism 9, and differences of means between the two groups was tested for statistical significance with t test. Results Single-cell sequencing revealed that compared with uninfected mice (2.41), the expression of Tsc22d3 continued to increase at 4 weeks (3.16) and 6 weeks after infection (3.76), and Tsc22d3 was highly expressed in the C3 subset of NK cells. The pathway of natural killer cell mediated cytotoxicity in the C3 subgroup were significantly activated. Flow cytometry showed that the proportions of Tsc22d3+NK92 cells were (0.24 ± 0.01)% and (1.40 ± 0.14)% in mouse hepatic NK cells 4 weeks and 6 weeks post-infection in the infection group, which were both higher than in the control group (0.12% ± 0.02%) (t = 12.110 and 22.010, both P values < 0.01). The proportions of IFN-γ and Prf1 positive cells were (1.66 ± 0.15)% and (53.23 ± 0.81)% in the Tsc22d3+NK92 group 24 h post-stimulation with SEA, which higher than in the NC group [(0.88 ± 0.13)% and (29.93 ± 1.85)%, respectively] (t = 6.800 and 20.010, both P values < 0.01), and the relative mRNA expression of IFN-γ and Prf1 was (1.53 ± 0.24) and (1.41 ± 0.04) in the Tsc22d3+NK92 group 24 h post-stimulation with SEA, which was higher than in the NC group [(1.00 ± 0.07) and (1.00 ± 0.140), respectively] (t = 3.573 and 4.973, P < 0.05 and 0.01). The relative mRNA expression of IFN-γ and Prf1 was (2.06 ± 0.39) and (1.54 ± 0.26) in the Tsc22d3+NK92 group 48 h post-stimulation with SEA, which was higher than in the NC group [(1.06 ± 0.44) and (1.00 ± 0.04), respectively] (t = 2.953 and 3.588, both P values < 0.05). Conclusion Tsc22d3 is highly expressed in the C3 subset of hepatic NK cells during the course of S. japonicum infection, and high Tsc22d3 expression may increase the cytotoxicity of NK cells.
Key words: Schistosoma japonicum; Tsc22d3; Liver fibrosis; Natural killer cell
| [1] | 张利娟, 何君逸, 杨帆, 等. 2023年全国血吸虫病防治进展[J]. 中国血吸虫病防治杂志, 2024, 36(3): 221-227. |
| Zhang LJ, He JY, Yang F, et al. Progress of schistosomiasis control in People's Republic of China in 2023[J]. Chin J Schisto Control, 2024, 36(3): 221-227. (in Chinese) | |
| [2] | Lo NC, Bezerra FSM, Colley DG, et al. Review of 2022 WHO guidelines on the control and elimination of schistosomiasis[J]. Lancet Infect Dis, 2022, 22(11): e327-e335. |
| [3] | Liu Z, Zhang L, Liang Y, et al. Pathology and molecular mechanisms of Schistosoma japonicum-associated liver fibrosis[J]. Front Cell Infect Microbiol, 2022, 12: 1035765. |
| [4] | Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression[J]. Nat Rev Gastroenterol Hepatol, 2021, 18(3): 151-166. |
| [5] | Jiao J, Sastre D, Fiel MI, et al. Dendritic cell regulation of carbon tetrachloride-induced murine liver fibrosis regression[J]. Hepatology, 2012, 55(1): 244-255. |
| [6] | Li S, Zhou B, Xue M, et al. Macrophage-specific FGF12 promotes liver fibrosis progression in mice[J]. Hepatology, 2023, 77(3): 816-833. |
| [7] | Liu Y, Lui EL, Friedman SL, et al. PTK787/ZK22258 attenuates stellate cell activation and hepatic fibrosis in vivo by inhibiting VEGF signaling[J]. Lab Invest, 2009, 89(2): 209-221. |
| [8] | Tsay HC, Yuan Q, Balakrishnan A, et al. Hepatocyte-specific suppression of microRNA-221-3p mitigates liver fibrosis[J]. J Hepatol, 2022, 77(1): 269. |
| [9] | 高元, 章孝成, 胡媛, 等. 自然杀伤细胞抑制血吸虫病肝纤维化作用的研究[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(2): 168-174. |
| Gao Y, Zhang XC, Hu Y, et al. Study on the inhibitory effect of natural killer cells on liver fibrosis of schistosomiasis[J]. Chin J Parasitol Parasit Dis, 2022, 40(2): 168-174. (in Chinese) | |
| [10] | Biron CA, Nguyen KB, Pien GC, et al. Natural killer cells in antiviral defense: Function and regulation by innate cytokines[J]. Annu Rev Immunol, 1999, 17: 189-220. |
| [11] | Robertson MJ. Role of chemokines in the biology of natural killer cells[J]. J Leukoc Biol, 2002, 71(2): 173-183. |
| [12] | Hu Y, Wang X, Wei Y, et al. Functional inhibition of natural killer cells in a BALB/c mouse model of liver fibrosis induced by Schistosoma japonicum infection[J]. Front Cell Infect Microbiol, 2020, 10: 598987. |
| [13] | Wijaya RS, Read SA, Schibeci S, et al. KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B[J]. J Hepatol, 2019, 71(2): 252-264. |
| [14] | Tao X, Zhang R, Du R, et al. EP3 enhances adhesion and cytotoxicity of NK cells toward hepatic stellate cells in a murine liver fibrosis model[J]. J Exp Med, 2022, 219(5): e20212414. |
| [15] | Gao Y, Zhang XC, Jiang TT, et al. Inhibition of hepatic natural killer cell function via the TIGIT receptor in schistosomiasis-induced liver fibrosis[J]. PLoS Pathog, 2023, 19(3): e1011242. |
| [16] | Zhou Z, Kim JW, Qi J, et al. Toll-Like receptor 5 signaling ameliorates liver fibrosis by inducing interferon β-modulated IL-1 receptor antagonist in mice[J]. Am J Pathol, 2020, 190(3): 614-629. |
| [17] | Zhang Y, Liu H, Jia W, et al. Myeloid differentiation protein 2 mediates angiotensin II-induced liver inflammation and fibrosis in mice[J]. Molecules, 2019, 25(1): 25. |
| [18] | Sheng J, Zhang B, Chen Y, et al. Capsaicin attenuates liver fibrosis by targeting Notch signaling to inhibit TNF-α secretion from M1 macrophages[J]. Immunopharmacol Immunotoxicol, 2020, 42(6): 556-563. |
| [19] | Steen EH, Wang X, Balaji S, et al. The role of the anti-inflammatory cytokine interleukin-10 in tissue fibrosis[J]. Adv Wound Care (New Rochelle), 2020, 9(4): 184-198. |
| [20] | Udomsinprasert W, Honsawek S, Poovorawan Y. Adiponectin as a novel biomarker for liver fibrosis[J]. World J Hepatol, 2018, 10(10): 708-718. |
| [21] | Shen B, Zhou C, Gu T, et al. Kuhuang alleviates liver fibrosis by modulating gut microbiota-mediated hepatic IFN signaling and bile acid synthesis[J]. Front Pharmacol, 2022, 13: 1080226. |
| [22] | Jovic D, Liang X, Zeng H, et al. Single-cell RNA sequencing technologies and applications: A brief overview[J]. Clin Transl Med, 2022, 12(3): e694. |
| [23] | Perez SA, Mahaira LG, Demirtzoglou FJ, et al. A potential role for hydrocortisone in the positive regulation of IL-15-activated NK-cell proliferation and survival[J]. Blood, 2005, 106(1): 158-166. |
| [24] | Bereshchenko O, Migliorati G, Bruscoli S, et al. Glucocorticoid-induced leucine zipper: Anovel anti-inflammatory molecule[J]. Front Pharmacol, 2019, 10: 308. |
| [25] | Bruscoli S, Riccardi C, Ronchetti S. GILZ as a regulator of cell fate and inflammation[J]. Cells, 2021, 11(1): 122. |
| [26] | Jones SA, Toh AE, Odobasic D, et al. Glucocorticoid-induced leucine zipper (GILZ) inhibits B cell activation in systemic lupus erythematosus[J]. Ann Rheum Dis, 2016, 75(4): 739-747. |
| [27] | Cannarile L, Delfino DV, Adorisio S, et al. Implicating the role of GILZ in glucocorticoid modulation of T-Cell activation[J]. Front Immunol, 2019, 10: 1823. |
| [28] | Bruscoli S, Biagioli M, Sorcini D, et al. Lack of glucocorticoid-induced leucine zipper (GILZ) deregulates B-cell survival and Results in B-cell lymphocytosis in mice[J]. Blood, 2015, 126(15): 1790-1801. |
| [29] | Flamini S, Sergeev P, Viana de Barros Z, et al. Glucocorticoid-induced leucine zipper regulates liver fibrosis by suppressing CCL2-mediated leukocyte recruitment[J]. Cell Death Dis, 2021, 12(5): 421. |
| [30] | Robert O, Boujedidi H, Bigorgne A, et al. Decreased expression of the glucocorticoid receptor-GILZ pathway in Kupffer cells promotes liver inflammation in obese mice[J]. J Hepatol, 2016, 64(4): 916-924. |
/
| 〈 |
|
〉 |